Clinical Study Of OPTIFAST® Meal Replacement Program Demonstrates Significant Sustained Weight Loss In Patients With Obesity

Nestlé Health Science today announced the publication of positive results from the OPTIWIN study in Obesity,1 the official peer-reviewed journal of The Obesity Society. OPTIWIN, which represents the largest year-long, randomized, clinical trial of a beha https://www.prnewswire.com/news-releases/clinical-study-of-optifast-meal-replacement-program-demonstrates-significant-sustained-weight-loss-in-patients-with-obesity-300749192.html